Genome-wide screening and identification of antigens for rickettsial vaccine development.
about
Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant ProteinAnaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics ApproachImmunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.Determining the repertoire of immunodominant proteins via whole-genome amplification of intracellular pathogens.Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.Knockout of an outer membrane protein operon of Anaplasma marginale by transposon mutagenesis.Antigenic Variation in Bacterial Pathogens.Genome-based bacterial vaccines: current state and future outlook.Vaccines based on structure-based design provide protection against infectious diseases.Anaplasma marginale Outer Membrane Protein A Is an Adhesin That Recognizes Sialylated and Fucosylated Glycans and Functionally Depends on an Essential Binding Domain.New approaches and omics tools for mining of vaccine candidates against vector-borne diseases.Reduced Infectivity in cattle for an outer membrane protein mutant of Anaplasma marginale.Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.Anaplasma phagocytophilum outer membrane protein A interacts with sialylated glycoproteins to promote infection of mammalian host cellsRickettsial entry into host cells: finding the keys to unlock the doorsA hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis.Detection and Characterisation of Anaplasma marginale and A. centrale in South Africa.
P2860
Q27304777-1AD5374E-4E4E-4D60-9186-5CCD5A924E12Q28074461-46A8702F-8004-4175-BC7C-152E171EE876Q30153495-8D4255B9-FD35-41F5-9EDC-B97C0FB44E00Q34257534-EA8A2179-DE5A-4A0F-AC77-0D4FABB0FFF2Q34431155-77DB2F91-219A-434F-A796-9D1B4F9AEBA0Q35145972-C86D1C10-94DC-4007-A30B-F4D47AC35764Q36725495-77C945FD-C1B8-47CD-B724-310E37398403Q38099207-C1557CCF-7B2E-4481-8F06-66088CFD6C2DQ38148782-131DAFD5-7731-4215-AC08-CD7BDA891A0CQ38725412-3004DD8A-8C63-4942-90A4-F5B98EED0F36Q38888271-949F6586-B775-4D62-B499-DDDFEC16DE61Q38919205-9FE805A5-EBB4-4804-A2DF-B4F07DC670EEQ40842064-17366422-DE27-4555-BBBE-A73D8A0AF381Q41584877-85398969-374A-42C6-B4C4-4BE6854AE219Q41585349-D82DED06-6223-4DF3-978F-103D9EF13290Q49914432-10D38D9A-394B-463D-8DBA-27ED366AE882Q54988661-A8DA2F8A-A813-41E5-AD7C-EF84B097A339
P2860
Genome-wide screening and identification of antigens for rickettsial vaccine development.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genome-wide screening and iden ...... ckettsial vaccine development.
@ast
Genome-wide screening and iden ...... ckettsial vaccine development.
@en
type
label
Genome-wide screening and iden ...... ckettsial vaccine development.
@ast
Genome-wide screening and iden ...... ckettsial vaccine development.
@en
prefLabel
Genome-wide screening and iden ...... ckettsial vaccine development.
@ast
Genome-wide screening and iden ...... ckettsial vaccine development.
@en
P2093
P2860
P1476
Genome-wide screening and iden ...... ckettsial vaccine development.
@en
P2093
Guy H Palmer
Kelly A Brayton
Susan M Noh
Wendy C Brown
P2860
P304
P356
10.1111/J.1574-695X.2011.00878.X
P577
2012-02-01T00:00:00Z